Contrast-induced nephropathy - a review of current literature and guidelines

Medical Science Monitor

Volumn 17, Issue 9, 2011, Pages

  Maliborski, Artur ^a   Zukowski, Paweł ^a   Nowicki, Grzegorz ^a   Bogusławska, Romana ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

CIN; CIN prevention; Contrast induced nephropathy; Risk factors of CIN

Indexed keywords

ACETYLCYSTEINE; AMINOGLYCOSIDE; ANGIOTENSIN II; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; CYSTATIN C; INTERLEUKIN 2; INULIN; IODINATED CONTRAST MEDIUM; LOOP DIURETIC AGENT; METFORMIN; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SODIUM CHLORIDE; THEOPHYLLINE;

ASTHMA; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DEHYDRATION; DIABETES MELLITUS; DIALYSIS; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; GOUT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOCRIT; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPERTHYROIDISM; INULIN CLEARANCE; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY SURGERY; LENGTH OF STAY; MORBIDITY; MORTALITY; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PROTEINURIA; REVIEW; SENESCENCE; ST SEGMENT ELEVATION; URINE VOLUME; VASOCONSTRICTION; VISCOSITY;

EID: 80054019359     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881923     Document Type: Review

References (55)

1. Imaging Economics 05.2007
2. Witkowski A: Kardiologia Interwencyjna w Polsce w 2007 r, Zarza{ogonek}d Sekcji Interwencji Sercowo-Naczyniowych PTK [in Polish]
3. Bartholomew BA, Harjai KJ, Dukkipati S et al: Impact of nephropathy after percutaneous coronary intervention and a method for risk strati-fcation. Am J Cardiol, 2004; 93: 1515-19
4. Renal Adverse Reactions, Guidelines ESUR, Spring 2008, No 7, http:// www.esur.org/ESUR_Guidelines.7.0.html
5. Reddan D, Fishman EK: Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists. EJR, 2008; 66(2): 235-45
6. Nash K, Hafeez A, Hou S: Hospital-acquired renal insuffcency. Am J. Kidney Dis, 2002; 39; 930-36
7. Goldenberg I, Matetzky S: Nephropathy induced by contrast media: pa-togenesis, risk factors and preventive strategies. CMAJ, 2005; 172(11): 1461-71
8. Marenzi G, Lauri G, Assanelli E et al: Contrast Induced Nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. JACC, 2004; 44(9): 1780-85
9. El-Hajjar M, Bashir I, Khan M et al: Incidence of Contrast-Induced Nephropathy in Patients With Chronic Renal Insuffciency Undergoing Multidetector Computed Tomographic Angiography Treated With Preventive Measures. Am J Cardiol, 2008; 102: 353-56
10. Uyarel H, Cam N, Ergelen M et al: Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction: incidence, a simple risk score, and prognosis, Med Sci, 2009; 5(4): 550-58
11. Wong GTC, Irwin MG: Contrast induced nephropathy. British Journal of Anesthesia, 2007; 4(99): 474-83
12. Tepel M, Aspelin P, Lameire N: Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach. Circulation, 2006; 113: 1799-806
13. Parfrey P: The clinical epidemiology of contrast-induced nephropathy, Cardiovasc Intervent Radiol, 2005
14. Gruberg L, Mintz G, Mehran R et al: The Prognostic Implications of Further Renal Function Deterioration Within 48 h of Interventional Coronary Procedures in Patients With Pre-existent Chronic Renal in-suffciency. J Am Coll Cardiol, 2000; 36(5): 1542-48
15. Manske CI, Sprafka JM, Strony JT: Contrast Nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med, 1990; 89: 615-20
16. Finn WF: The clinical and renal consequences of contrast-induced ne-phropathy. Nephrol Dial Transplant, 2006, 21(Suppl.1), i2-i10
17. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort analisys. JAMA, 1996; 275, 1489-94
18. Rihal CS, Textor SC, Grill DE et al: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation, 2002; 105: 2259-64
19. Rudnick M, Feldman H: Contrast-Induced Nephropathy: What are the true clinical consequences? Clin J Am Soc Nephrol, 2008; 3: 263-72
20. Gruberg L, Mehran R, Dangas G et al: Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv, 2001; 52: 409-16
21. Angielski S, Rogulski J: Biochemia Kliniczna, Warszawa, 1991, 662-70 [in Polish]
22. van Rossum LK, Cransberg K, de Rijke YB: Determination of inulin clearance by single injection or infusion in children. Pediatric Nephrology, 2005; 20(6): 777-81
23. Beumeister B, Besenthal I, Liebich H: Diagnostyka laboratoryjna, Urban&Partner, Wrocław, 2003; 133-35 [in Polish]
24. Perlemoine C, Beauvieux BC, Rigalleau V: Interest of cystatin C in screening diabetic patients for early impairment of renal function. Metabolism, 2003; 52(10): 1258-64
25. White C, Akbari A, Hussain N: Estimating Glomerular Filtration Rate in Kidney Transplantation: A Comparison between Serum Creatinine and Cystatin C-Based Methods. J Am Soc Nephrol, 2005; 16: 3763-70
26. Beauvieux MC, Le Moigne F, Lasseur C et al: New predictive equations improve monitoring of kidney function in patients with diabetes. Diab Care, 2007; 30: 1988-94
27. Hill G, McDonald C: Technical brief on Cockcroft-Gault formula for estimating creatinine clearance, Schwartz equation for Glomerular Filtration Rate and MDRD formulae,LOINC, Technical Brief
28. Sekowska R, Roszkowska-Blaim R: Ocena fltracji kłe{ogonek}buszkowej u dzieci z przewlekła{ogonek} choroba{ogonek} nerek w oparciu o klirens cystatyny C. Pol Merk Lek, 2008, XXIV(Supl.4), 61 [in Polish]
29. Schwartz GF et al: A Simple Estimate of GFR in Children Using Body Length and Plasma Creatinine. Pediatrics, 1976; 58: 259-63
30. Filler G, Foster J, Acker A et al: The Cockcroft-Gault formula should not be used in children. Kidney Int, 2005, 67(6): 2321-24
31. Sendeski M, Patzak A, Pallone TL et al: Iodixanol, constriction of medullary descending vasa recta and risk for contrast medium induced ne-phropathy, Radiology, 2009; 251(3): 697-704
32. Seeliger E, Flemming B, Wronski T: Viscosity of Contrast Media Perturbs Renal Hemodynamics, J Am Soc Nephrol, 2007; 18: 2912-20
33. Mehran R, Aymong ED, Nikolsky E et al: A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol, 2004; 44: 1393-99
34. Detrenis S, Meschi M, Musini S: Lights and shadows on the pathogen-esis of contrast-induced nephropathy state of the art. Nephrol Dial Transplant, 2005; 20: 1542-50
35. Heinrich MC, Haberle L, Muller V: Nephrotoxicity of iso-osmolar Iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology, 2009; 250(1): 68-86
36. Pannu N, Wiebe N et al: Prophylaxis Strategies for Contrast-Induced Nephropathy. JAMA, 2006; 295: 2765-79
37. Toprak O, Cirit M, Yesil M: Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant, 2007: 22: 819-26
38. Venkataraman R, Kellum J: Prevention of Acute Renal Failure. Chest, 2007; 131: 300-8
39. Caixeta A, Nikolsky E, Mehran R: Contrast-induced Nephropathy: Prevention and Management of High-risk Patients, Indian Heart J, 2008; 60: 524-31
40. Cirit M, Toprak O, Yesil M: Angiotensin-Converting Enzyme Inhibitors as a Risk Factor for Contrast-Induced Nephropathy. Nephron Clin Pract, 2006; 104: c20-27
41. Sancewicz-Pach K, Ogarek I: Potentially nephrotoxic drugs and substances. Przegla{ogonek}d Lekarski, 2001; 58(4): 185-91
42. Adolpha E, Holdt-Lehmannb B, Chatterjee T et al: Renal Insuffciency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy. Coronary Artery Disease, 2008; 19: 413-19
43. McCullough P: Contrast-Induced Acute Kidney Injury. J Am Coll Cardiol, 2008, 51(15): 1419-28
44. Poletti PA, Sudan P, Platon A et al: IV Nacetylocysteine and Emergency CT: Use of serum creatinine and Cystatin C as markers of Radiocontrast Nefrotoxicity. AJR, 2007: 189
45. Persson PB, Patzak A: Renal haemodynamics alterations in contrast medium - induced nephropathy and the beneft of hydration. Nephrol Dial Transplant, 2005; 20(Suppl.1): i2-i5
46. Koch J, Plum J, Grabensee B et al: Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radio-contrast media? Nephrology Dialysis Transplantation, 2000; 15: 43-49
47. Kelly AM, Dwamena B, Cronin P et al: Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy, Ann Intern Med, 2008; 148(4): 284-94
48. Maioli M, Toso A, Leoncini M et al: Sodium Bicarbonate Versus Saline for the Prevention of Contrast-Induced Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention. J Am Coll Cardiol, 2008; 52: A29-30
49. Schmidt P, Pang D, Nykamp D et al: N-Acetylcysteine and Sodium Bicarbonate Versus N-Acetylcysteine and Standard Hydration for the Prevention of Radiocontrast-Induced Nephropathy Following Coronary Angiography. Ann Pharmacother, 2006; 41(1): 46-50
50. Ozcan EE, Guneri S, Akdeniz B et al: Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J, 2007; 154(3): 539-44
51. Spargias K, Alexopoulos E, Kyrzopoulos S et al: Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation, 2004; 110: 2837-42
52. From A, Bartholmai B, Williams A et al: Sodium Bicarbonate is Associated with an Increased Incidence of Contrast Nephropathy: A Retrospective Cohort Study of 7977 Patients at Mayo Clinic. Clin J Am Soc Nephrol, 2008; 3: 10-18
53. Solomon R, Werner C, Mann D: Effects of Saline, Mannitol, and Furosemide on Acute Decreases in Renal Function Induced by Radiocontrast Agents. NEJM, 1994; V331: 1416-20
54. Huber W, Ilgmann K, Page M et al: Effect of Theophylline on Contrast Material - induced Nephropathy in Patients with Chronic Renal Insuffciency: Controlled, Randomized, Double-blinded Study. Radiology, 2002; 223(3): 772-79
55. Bagshaw S, Ghali W: Theophylline for Prevention of Contrast-Induced Nephropathy A Systematic Review and Meta-analysis, Arch Intern Med, 2005; 165: 1087-93